CoChat
Sign Up
Cited by 347Immune Cell Function and InteractionImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

Open access
Lakshmikanth, Tadepally, Burke, Shannon, Ali, Talib Hassan, Kimpfler, Silvia, Ursini, Francesco, Ruggeri, Loredana, Capanni, Marusca, Umansky, Viktor, Paschen, Annette, Sucker, Antje, Pende, Daniela, Groh, Veronika, Biassoni, Roberto, Höglund, Petter, Kato, Masashi, Shibuya, Kazuko, Schadendorf, Dirk, Anichini, Andrea, Ferrone, Soldano, Velardi, Andrea, Kärre, Klas, Shibuya, Akira, Carbone, Ennio, Colucci, Francesco·2009·Journal of Clinical Investigation
DOI 10.1172/jci36022PMC PMC2673866
Open this paper in CoChat — free account

Abstract

NK cells use a variety of receptors to detect abnormal cells, including tumors and their metastases. However, in the case of melanoma, it remains to be determined what specific molecular interactions are involved and whether NK cells control metastatic progression and/or the route of dissemination. Here we show that human melanoma cell lines derived from LN metastases express ligands for natural cytotoxicity receptors (NCRs) and DNAX accessory molecule-1 (DNAM-1), two emerging NK cell receptors key for cancer cell recognition, but not NK group 2 member D (NKG2D). Compared with cell lines derived from metastases taken from other anatomical sites, LN metastases were more susceptible to NK cell lysis and preferentially targeted by adoptively transferred NK cells in a xenogeneic model of cell therapy. In mice, DNAM-1 and NCR ligands were also found on spontaneous melanomas and melanoma cell lines. Interference with DNAM-1 and NCRs by antibody blockade or genetic disruption reduced killing of melanoma cells. Taken together, these results show that DNAM-1 and NCRs are critical for NK cell-mediated innate immunity to melanoma cells and provide a background to design NK cell-based immunotherapeutic strategies against melanoma and possibly other tumors.

Overview

Integrity signals

Registry

Crossref · 10.1172/jci36022

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 40 references

Research works printed but not linked: 5

  1. Recio, 2002, Cancer Res., 62, 6724
  2. 10.1038/sj.jid.5701111 · DOI
  3. Albert, 1984, Invest. Ophthalmol. Vis. Sci., 25, 1284
  4. Kan-Mitchell, 1989, Invest. Ophthalmol. Vis. Sci., 30, 829
  5. Huang, 1994, Cancer Immunol. Immunother., 38, 399

Cited by

Sorted by citations

Items 301–347 of 347

Related

See all

Metadata

Authors
Lakshmikanth, T., Burke, S., Ali, T. H., Kimpfler, S., Ursini, F., Ruggeri, L., Capanni, M., Umansky, V., Paschen, A., Sucker, A., Pende, D., Groh, V., Biassoni, R., Höglund, P., Kato, M., Shibuya, K., Schadendorf, D., Anichini, A., Ferrone, S., Velardi, A., Kärre, K., Shibuya, A., Carbone, E., & Colucci, F.
Affiliations
  • Magna Graecia University (IT)
  • Babraham Institute (GB)
  • Heidelberg University (DE)
  • University of Perugia (IT)
  • Ospedale Policlinico San Martino (IT)
  • Fred Hutch Cancer Center (US)
  • Istituto Giannina Gaslini (IT)
  • Karolinska Institutet (SE)
  • Chubu University (JP)
  • University of Tsukuba (JP)
  • Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
  • University of Pittsburgh (US)
ORCID
Venue
Journal of Clinical Investigation
Publisher
American Society for Clinical Investigation
Published
2009-05-01
Volume
119
Issue
5
Pages
1251-1263
ISSN
0021-9738 (ISSN-L)
DOI
10.1172/jci36022
PMC
PMC2673866
OpenAlex
W2143731593
Cited by
347
References
40
Citations by year
2026: 4 · 2025: 9 · 2024: 10 · 2023: 14 · 2022: 14 · 2021: 24 · 2020: 29 · 2019: 31 · 2018: 15 · 2017: 24 · 2016: 26 · 2015: 26 · 2014: 27 · 2013: 23 · 2012: 25
FWCI
10.21
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
Funders
  • Cancerfonden
  • Karolinska Institutet
  • Vetenskapsrådet
  • Associazione Italiana per la Ricerca sul Cancro
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council (BBS/E/B/00001212, BBS/E/B/0000C212)
  • National Cancer Institute (R01CA110249)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
natural killer cells, natural cytotoxicity receptors, DNAM-1, melanoma, lymph node metastasis, NK cell-mediated lysis, NK cell receptors, NKG2D, innate immunity, NK cell therapy, antibody blocking, adoptive NK cell transfer, tumor recognition
MeSH terms
T Lineage-Specific Activation Antigen 1, Animals, Antibodies, Antigens, Differentiation, T-Lymphocyte, Antigens, Ly, Cytotoxicity Tests, Immunologic, Cytotoxicity, Immunologic, DNA-Binding Proteins, Humans, Killer Cells, Natural, Ligands, Lymphatic Metastasis, Melanoma, Melanoma, Experimental, Mice, Inbred Strains, Mice, Transgenic, Lymphocyte Function-Associated Antigen-1, Immunotherapy, Adoptive, Mice, SCID, Mice, Inbred NOD, Mice, Knockout, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Interleukin Receptor Common gamma Subunit, Natural Killer T-Cells, Natural Cytotoxicity Triggering Receptor 1, Receptors, Natural Cytotoxicity Triggering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review